134 related articles for article (PubMed ID: 31863140)
1. Survival with Follicular and Hurthle Cell Microcarcinoma Compared to Papillary Thyroid Microcarcinoma: A Population Study of 84,532 Patients.
Khokar AM; Holoubek SA; Kuchta KM; Winchester DJ; Prinz RA; Moo-Young TA
World J Surg; 2020 Feb; 44(2):469-478. PubMed ID: 31863140
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma.
Kim WY; Kim HY; Son GS; Bae JW; Lee JB
J Cancer Res Ther; 2014; 10(1):50-5. PubMed ID: 24762486
[TBL] [Abstract][Full Text] [Related]
3. Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.
Zhi J; Zhao J; Gao M; Pan Y; Wu J; Li Y; Li D; Yu Y; Zheng X
Int J Clin Oncol; 2018 Feb; 23(1):59-65. PubMed ID: 28744725
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinicopathological features and prognosis of papillary thyroid carcinoma and microcarcinoma: A population-based propensity score matching analysis.
Qian B; Hu L; Zhang S; Zhu J; Mei L; Huang T; Qu X
Front Endocrinol (Lausanne); 2022; 13():944758. PubMed ID: 35992148
[TBL] [Abstract][Full Text] [Related]
5. Margin Positivity and Survival in Papillary Thyroid Microcarcinoma: A National Cancer Database Analysis.
Lee CI; Kutlu O; Khan ZF; Picado O; Lew JI
J Am Coll Surg; 2021 Oct; 233(4):537-544. PubMed ID: 34265429
[TBL] [Abstract][Full Text] [Related]
6. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
[No Abstract] [Full Text] [Related]
7. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.
Siddiqui S; White MG; Antic T; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
Thyroid; 2016 Jun; 26(6):807-15. PubMed ID: 27117842
[TBL] [Abstract][Full Text] [Related]
8. Wolf in Sheep's Clothing: Papillary Thyroid Microcarcinoma in the US.
Al-Qurayshi Z; Nilubol N; Tufano RP; Kandil E
J Am Coll Surg; 2020 Apr; 230(4):484-491. PubMed ID: 32220437
[TBL] [Abstract][Full Text] [Related]
9. Papillary thyroid microcarcinoma with minimal extrathyroidal extension. Is its course so indolent that it requires a less aggressive treatment?
Ruiz Pardo J; Ríos Zambudio A; Rodríguez González JM; Paredes Quiles M; Soriano Giménez V; Oviedo Ramírez MI; Hernández Martínez AM; Parrilla Paricio P
Rev Clin Esp (Barc); 2021 Mar; 221(3):131-138. PubMed ID: 33998460
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.
Vasileiadis I; Karatzas T; Vasileiadis D; Kapetanakis S; Charitoudis G; Karakostas E; Kouraklis G
Head Neck; 2014 Apr; 36(4):564-70. PubMed ID: 23780707
[TBL] [Abstract][Full Text] [Related]
11. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
12. The relationship between lipotoxicity and risk of extrathyroidal extension in papillary thyroid microcarcinoma.
Li C; Guan H; He Q; Zhao Y; Liang N; Zhang J; Dionigi G; Sun H
Endocrine; 2021 Dec; 74(3):646-657. PubMed ID: 34189681
[TBL] [Abstract][Full Text] [Related]
13. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
[TBL] [Abstract][Full Text] [Related]
14. Active surveillance for young patients with insular thyroid cancer: an initial and novel finding.
Liu Z; Zeng W; Zhou L; Zhou W; Chen D; Feng H; Wei W; Zhang C; Wang M; Guo L
Am J Transl Res; 2019; 11(1):176-187. PubMed ID: 30787977
[TBL] [Abstract][Full Text] [Related]
15. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
[TBL] [Abstract][Full Text] [Related]
16. Bilateral multifocality, a marker for aggressive disease, is not an independent prognostic factor for papillary thyroid microcarcinoma: A propensity score matching analysis.
Yan T; Qiu W; Song J; Ying T; Fan Y; Yang Z
Clin Endocrinol (Oxf); 2021 Jul; 95(1):209-216. PubMed ID: 33660317
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes and prognostic factors in papillary thyroid microcarcinoma patients with distant metastases.
Weng HY; Yan T; Qiu WW; Xi C; Hou LY; Yang ZL; Qiu ZL
Endocrine; 2022 Feb; 75(2):495-507. PubMed ID: 34699028
[TBL] [Abstract][Full Text] [Related]
18. [Risk Factors of Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma:An Analysis Based on Data from the Surveillance, Epidemiology and End Results Database].
Zheng KS; Zeng Y; Chen C; Wu YZ; Chen B; Ying WB; Zheng KW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):736-743. PubMed ID: 30606382
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients.
Zhang L; Wei WJ; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y
J Clin Endocrinol Metab; 2012 Apr; 97(4):1250-7. PubMed ID: 22319042
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension.
Zhang X; Zhang L; Xue S; Wang P; Chen G
Asian J Surg; 2019 Apr; 42(4):563-570. PubMed ID: 30078501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
